Conference abstractPublished 27 Sep 2017
C/EBP- positively regulates MDSC expansion and endothelial VEGFR2 expression in tumor development
National Cancer Institutes, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vascular endothelial cells and Gr-1+CD11b+ myeloid derived suppressor cells (MDSCs) are two important components that constitute the tumor microenvironment. Targeting these cells offers the potential to halt tumor growth. In this study, we report a common mediator in C/EBP-d that regulates both components and aids in tumor development. C/EBP-d is elevated in tumor derived MDSCs. Interestingly, genetic deletion of C/EBP-d in mice significantly impaired MDSC expansion in response to tumor progression, but it had no effect on Gr-1+CD11b+ cell production in normal development. It suggests a specific role of C/EBP-d in emergency myelopoiesis under tumor conditions. Consistent with the pro tumor functions of MDSCs, loss of C/EBP-d resulted in reduced tumor angiogenesis and tumor growth. Moreover, we found expression of C/EBP-d in vascular endothelial cells. C/EBP-d regulated cell motility, endothelial network formation and vascular sprouting. Notably, inactivation of C/EBP-d in endothelial cells specifically inhibited the expression of VEGFR2 but not VEGFR1. Ectopic expression of C/EBP-d increased and knockdown of the gene decreased VEGFR2 expression. C/EBP-d is recruited to the promoter region of VEGFR2, indicative of transcriptional regulation. Collectively, this study has identified a positive mediator in C/EBP-d, which regulates tumor induced MDSC expansion and VEGFR2 expression in endothelium. Considering the importance of MDSCs and endothelial cells in tumor progression, targeting C/EBP-d may provide an interesting means for cancer therapy, killing two birds with one stone.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “P Charles Lin”